Medical treatment with ulipristal acetate for uterine fibroids: Will it be resurrected?

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Medical treatment with ulipristal acetate for uterine fibroids: Will it be resurrected?

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Medical treatment with ulipristal acetate for uterine fibroids: Will it be resurrected?

Conservative treatment of symptomatic uterine fibroids continues to be a major gynecologic challenge. Although surgical approaches such as myomectomy are effective, it becomes less effective in younger patients as new myomas emerge overtime. Medical treatment with gonadotropin releasing hormone (GnR…

VOLUME 116, ISSUE 1, P80

Author:

James H. Liu, M.D.

Abstract:

Reflections on "Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial" by Osuga et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content